Plasma Cell-Free DNA as a Novel Biomarker for the Diagnosis and Monitoring of Atherosclerosis

Atherosclerosis (AS) is the leading cause of cardiovascular diseases (CVDs) with a high rate of mortality worldwide. Plasma cell-free DNA (cfDNA), mainly originating from apoptosis, necrosis, and active secretion, has been recognized as a promising biomarker for the diagnosis and prognosis of multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Benheng, Li, Kexin, Lou, Xiaoying, Guo, Ye, Wang, Yidong, Wu, Lianpin, Zhang, Donghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600586/
https://www.ncbi.nlm.nih.gov/pubmed/36291116
http://dx.doi.org/10.3390/cells11203248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600586/
https://www.ncbi.nlm.nih.gov/pubmed/36291116
http://dx.doi.org/10.3390/cells11203248

Ejemplares similares